Genoptix, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Genoptix, Inc. - overview
Established
1999
Location
Carlsbad, CA, US
Primary Industry
Healthcare Specialists
About
Founded in 1999 and based in California, US, Genoptix, Inc. provides specialized oncology diagnostic and informatics services. In January 2017, Ampersand Capital Partners, along with 1315 Capital and company management, agreed to acquire Genoptix, Inc. from Novartis International AG.
Financial terms were not disclosed. The company operates a hematopathology center and clinical oncology laboratory that focuses on hematology and solid tumor testing. The company produces specialized diagnostic services to hematologists, oncologists, and pathologists.
Primary Industry
Healthcare Specialists
Sub Industries
Oncology/Cancer Treatment
Website
www.genoptix.com
Company Stage
Acquired
Total Amount Raised
Subscriber access only
Genoptix, Inc. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Trade Sale | Completed | Genoptix, Inc. | - | ||||||||
| Buyout | Completed | Genoptix, Inc. | - |
Displaying 1 - 2 of 2
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.